Dispersive today announced the successful completion of an independent HIPAA compliance examination conducted by Johanson Group LLP. The examination evaluated Dispersive’s virtual networking platform against the requirements defined in the HIPAA Audit Program.
This milestone reinforces Dispersive’s commitment to protecting sensitive clinical, operational, research, and patient data across distributed networks. In particular, healthcare providers, telemedicine platforms, pharmaceutical companies, clinical research organizations (CROs), and critical infrastructure environments.
Dispersive’s stealth networking platform obfuscates and splits traffic across multiple dynamic network paths, making communications extremely difficult to detect, intercept, or disrupt. The result is an overlay network that provides zero-trust access, multi-path resilience, and quantum-resistant encryption that does not require organizations to rip and replace their existing infrastructure.
Healthcare organizations are increasingly prioritizing architectures that:
- Isolate sensitive systems and clinical workloads
- Protect remote care delivery and hybrid workforce access
- Reduce ransomware and OT/IoT exposure
- Support secure multi-cloud and AI-assisted workflows
- Ensure continuity during outages and degradation events
Dispersive’s HIPAA examination underscores the company’s continued investment in compliance, secure-by-design networking, and trust for regulated industries.
Related
This entry was posted on October 27, 2025 at 5:47 pm and is filed under Commentary with tags Dispersive. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Dispersive Completes HIPAA Compliance Examination
Dispersive today announced the successful completion of an independent HIPAA compliance examination conducted by Johanson Group LLP. The examination evaluated Dispersive’s virtual networking platform against the requirements defined in the HIPAA Audit Program.
This milestone reinforces Dispersive’s commitment to protecting sensitive clinical, operational, research, and patient data across distributed networks. In particular, healthcare providers, telemedicine platforms, pharmaceutical companies, clinical research organizations (CROs), and critical infrastructure environments.
Dispersive’s stealth networking platform obfuscates and splits traffic across multiple dynamic network paths, making communications extremely difficult to detect, intercept, or disrupt. The result is an overlay network that provides zero-trust access, multi-path resilience, and quantum-resistant encryption that does not require organizations to rip and replace their existing infrastructure.
Healthcare organizations are increasingly prioritizing architectures that:
Dispersive’s HIPAA examination underscores the company’s continued investment in compliance, secure-by-design networking, and trust for regulated industries.
Share this:
Like this:
Related
This entry was posted on October 27, 2025 at 5:47 pm and is filed under Commentary with tags Dispersive. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.